Ipsen (IPSEY) stock rises after the FDA offered Breakthrough Therapy Designation for its antibody therapy IPN60340 in acute myeloid leukemia. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback